|
Schering-Plough Corp.
Ticker Symbol: SGP* CUSIP: 806605101 Exchange: NYSE
* NOTE: This security is no longer trading as of 11/03/2009
Company's Online Profile
BUSINESS: Schering-Plough is a global science-based company that discovers, develops and manufactures pharmaceuticals for three customer markets - human prescription, consumer and animal health. While most of the research and development activity is directed toward prescription products, there are important applications of this central research and development platform into the consumer healthcare and animal health products. Schering-Plough also accesses external innovation via partnering, in-licensing and acquisition for all three customer markets. Schering-Plough is based in Kenilworth, N.J.
|
Notes: November 3, 2009 -- Merck & Co., Inc. (NYSE: MRK) and Schering-Plough Corporation (NYSE: SGP) today announced that they will complete their merger shortly after 4:00PM ET today. The companies will begin combined operations tomorrow, November 4, 2009. As previously announced, Schering-Plough will change its name to Merck and its common stock will trade under the ticker symbol “MRK” on the New York Stock Exchange. Under the terms of the agreement, Schering-Plough shareholders will receive 0.5767 shares of the newly combined company and $10.50 in cash for each share of Schering-Plough. Each Merck common share will automatically become a common share of the newly combined company.
|
Large Cap Stock -
Market Value $44.2 Billion
|
Company's Online Information Links
|
| Company's Online SEC EDGAR Filings |
| Address and Phone Numbers |
| Address: 2000 Galloping Hill Road, Kenilworth, NJ 07033 |
| Main Phone Number |
908-298-4000 |
| Fax Number |
908-298-7082 |
| Investor Relations
Alex Kelly
|
908-298-7436
|
| CEO - Fred Hassan |
CFO - Robert J. Bertolini |
Find a problem? Please use our Feedback Page or Email us.
Have you filled out our Guestbook? If not, please do.
|
|
